Invesco Ltd.
· Reduced
Change
−1.2M
Δ Own
−93.6%
Date
Q1 2026
PI
| Investor | Type | Est. change | Change | Δ Own | Date | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Invesco Ltd.
· Reduced
Change
−1.2M
Δ Own
−93.6%
Date
Q1 2026
|
Invesco Ltd. | Reduced· Q1 2026 | – | −1.2M | −93.6% | Q1 2026 | |||||
|
Driehaus Capital Management LLC
· Exited
Change
−737K
Δ Own
−100.0%
Date
Q1 2026
|
Driehaus Capital Management LLC | Exited· Q1 2026 | – | −737K | −100.0% | Q1 2026 | |||||
|
Alyeska Investment Group, L.P.
· New
Change
+735K
Date
Q1 2026
|
Alyeska Investment Group, L.P. | New· Q1 2026 | – | +735K | – | Q1 2026 | |||||
|
Whale Rock Capital Management LLC
· Reduced
Change
−482K
Δ Own
−54.3%
Date
Q1 2026
|
Whale Rock Capital Management LLC | Reduced· Q1 2026 | – | −482K | −54.3% | Q1 2026 | |||||
|
Manufacturers Life Insurance Company, the
· Added
Change
+409K
Date
Q1 2026
|
Manufacturers Life Insurance Company, the | Added· Q1 2026 | – | +409K | – | Q1 2026 | |||||
|
T. Rowe Price Associates
· Reduced
Change
−387K
Date
Q1 2026
|
T. Rowe Price Associates | Reduced· Q1 2026 | – | −387K | – | Q1 2026 | |||||
|
Norges
· Exited
Change
−317K
Δ Own
−100.0%
Date
Q1 2026
|
Norges | Exited· Q1 2026 | – | −317K | −100.0% | Q1 2026 | |||||
|
Point72 Asset Management, L.P.
· New
Change
+289K
Date
Q1 2026
|
Point72 Asset Management, L.P. | New· Q1 2026 | – | +289K | – | Q1 2026 | |||||
|
Capital World Investors
· Added
Change
+262K
Date
Q1 2026
|
Capital World Investors | Added· Q1 2026 | – | +262K | – | Q1 2026 | |||||
|
FMR LLC
· Reduced
Change
−220K
Δ Own
−4.9%
Date
Q1 2026
|
FMR LLC | Reduced· Q1 2026 | – | −220K | −4.9% | Q1 2026 | |||||
|
Capital International Investors
· Reduced
Change
−212K
Date
Q1 2026
|
Capital International Investors | Reduced· Q1 2026 | – | −212K | – | Q1 2026 | |||||
|
State Street
· Added
Change
+208K
Date
Q1 2026
|
State Street | Added· Q1 2026 | – | +208K | – | Q1 2026 | |||||
|
Fiera Capital Corp
· New
Change
+203K
Date
Q1 2026
|
Fiera Capital Corp | New· Q1 2026 | – | +203K | – | Q1 2026 | |||||
|
UBS Group AG
· Added
Change
+189K
Date
Q1 2026
|
UBS Group AG | Added· Q1 2026 | – | +189K | – | Q1 2026 | |||||
|
Vanguard
· Added
Change
+173K
Date
Q1 2026
|
Vanguard | Added· Q1 2026 | – | +173K | – | Q1 2026 | |||||
| Insider | Title | Type | Price | Qty | Value | Owned | ΔOwn | Trade date | Filed date | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Diorio Chris Ph.d.
· Director
Gift (G)
-10K
|
Diorio Chris Ph.d. | Director | Gift (G) | – | -10K | – | 372K | −2.6% | Jul 13, 2026 | Jul 14, 2026 | |||||||||
|
Baker Cary
· Officer
4 operations
0
|
Baker Cary | Officer | 4 operations | – | 0 | – | 4K | – | Jun 23, 2026 | Jun 24, 2026 | |||||||||
|
Baker Cary
· Officer
Tax withholding or exercise payment (F)
-$53K
|
Baker Cary | Officer | Tax withholding or exercise payment (F) | $125.22 | -424 | -$53K | 90K | −0.5% | Jun 23, 2026 | Jun 24, 2026 | |||||||||
|
Diorio Chris Ph.d.
· Director
4 operations
0
|
Diorio Chris Ph.d. | Director | 4 operations | – | 0 | – | 13K | – | Jun 23, 2026 | Jun 24, 2026 | |||||||||
|
Diorio Chris Ph.d.
· Director
Tax withholding or exercise payment (F)
-$150K
|
Diorio Chris Ph.d. | Director | Tax withholding or exercise payment (F) | $125.22 | -1K | -$150K | 382K | −0.3% | Jun 23, 2026 | Jun 24, 2026 | |||||||||
|
Diorio Chris Ph.d.
· Director
Gift (G)
-10K
|
Diorio Chris Ph.d. | Director | Gift (G) | – | -10K | – | 380K | – | Jun 15, 2026 | Jun 16, 2026 | |||||||||
|
Sylebra Capital LLC
· Director
Sell
−$1.5M
|
Sylebra Capital LLC | Director | Sell | $127.36 | −12K | −$1.5M | 783K | – | Jun 9, 2026 | Jun 10, 2026 | |||||||||
|
Sylebra Capital LLC
· Director
2 operations
−$5.9M
|
Sylebra Capital LLC | Director | 2 operations | $125.97–$130.07 | −46K | −$5.9M | 795K | – | Jun 8, 2026 | Jun 10, 2026 | |||||||||
|
Sylebra Capital LLC
· Director
2 operations
−$5.9M
|
Sylebra Capital LLC | Director | 2 operations | $122.50–$128.87 | −47K | −$5.9M | 841K | – | Jun 5, 2026 | Jun 9, 2026 | |||||||||
|
Sylebra Capital LLC
· Director
Sell
−$4.6M
|
Sylebra Capital LLC | Director | Sell | $136.84 | −33K | −$4.6M | 888K | – | Jun 4, 2026 | Jun 8, 2026 | |||||||||
|
Sylebra Capital LLC
· Director
Sell
−$879K
|
Sylebra Capital LLC | Director | Sell | $139.17 | −6K | −$879K | 921K | – | Jun 3, 2026 | Jun 4, 2026 | |||||||||
|
Sylebra Capital LLC
· Director
Sell
−$5.5M
|
Sylebra Capital LLC | Director | Sell | $142.31 | −39K | −$5.5M | 928K | – | Jun 2, 2026 | Jun 4, 2026 | |||||||||
|
Sylebra Capital LLC
· Director
Sell
−$1.0M
|
Sylebra Capital LLC | Director | Sell | $144.29 | −7K | −$1.0M | 967K | – | Jun 1, 2026 | Jun 2, 2026 | |||||||||
|
Sylebra Capital LLC
· Director
Sell
−$7.3M
|
Sylebra Capital LLC | Director | Sell | $150.78 | −49K | −$7.3M | 974K | – | May 29, 2026 | Jun 2, 2026 | |||||||||
|
Gibson Daniel Patrick
· Director
2 operations
0
|
Gibson Daniel Patrick | Director | 2 operations | – | 0 | – | 0 | – | May 28, 2026 | May 29, 2026 | |||||||||
N
A
M
G
A
A
322 reporting institutions disclosed PI position changes in the Q1 2026 snapshot.
For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.
An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.
Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.
Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.
A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.